Table 1 Clinical characteristics of all patients including of 20 SR patients and 20 AF patients
From: miR-21 enhances cardiac fibrotic remodeling and fibroblast proliferation via CADM1/STAT3 pathway
Group | SR | AF |
|---|---|---|
Case (Male/Female) | 20 (11/9) | 20 (10/10) |
Age (Year) | 53.2 ± 10.5 | 46.7 ± 9.1 |
LVEF (%) | 55.6 ± 6.9 | 56.8 ± 7.3 |
LAD (mm) | 43.3 ± 4.2 | 58.1 ± 9.5** |
NYHA-C (II/III/IV) | 4/11/5 | 3/12/5 |